Coherus Oncology, Inc.
CHRS
$1.60
$0.020.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 172.13M | 191.66M | 237.64M | 82.41M | 125.99M |
| Total Receivables | 18.42M | 250.50M | 119.64M | 62.44M | 122.33M |
| Inventory | 3.17M | 2.05M | 4.51M | 3.52M | 4.21M |
| Prepaid Expenses | 12.99M | 16.75M | 18.42M | 22.84M | 16.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 138.97M | 72.18M |
| Total Current Assets | 206.71M | 460.96M | 380.21M | 310.18M | 341.58M |
|
|
|||||
| Total Current Assets | 206.71M | 460.96M | 380.21M | 310.18M | 341.58M |
| Net Property, Plant & Equipment | 4.30M | 1.63M | 1.91M | 2.26M | 7.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 46.24M | 49.48M | 52.31M | 52.98M | 53.65M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.10M | 4.45M | 5.04M | 5.66M | 46.21M |
| Total Assets | 258.34M | 516.52M | 439.46M | 371.07M | 448.53M |
|
|
|||||
| Total Accounts Payable | 9.92M | 24.89M | 37.62M | 40.93M | 28.46M |
| Total Accrued Expenses | 63.58M | 91.71M | 120.25M | 185.96M | 227.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.83M | 1.79M | 1.76M | 1.80M | 2.84M |
| Total Finance Division Other Current Liabilities | 65.07M | 253.91M | 104.00M | 26.36M | 24.65M |
| Total Other Current Liabilities | 65.07M | 253.91M | 104.00M | 26.36M | 24.65M |
| Total Current Liabilities | 140.39M | 372.30M | 263.63M | 255.04M | 282.98M |
|
|
|||||
| Total Current Liabilities | 140.39M | 372.30M | 263.63M | 255.04M | 282.98M |
| Long-Term Debt | 51.08M | 50.58M | 49.97M | 294.85M | 292.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.46M | 1.95M | 2.41M | 2.85M | 3.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.41M | 3.92M | 3.63M | 1.79M | 1.73M |
| Total Liabilities | 197.33M | 428.75M | 319.64M | 554.54M | 580.52M |
|
|
|||||
| Common Stock & APIC | 1.44B | 1.43B | 1.43B | 1.42B | 1.42B |
| Retained Earnings | -1.38B | -1.35B | -1.31B | -1.61B | -1.55B |
| Treasury Stock & Other | -195.00K | -203.00K | -275.00K | -275.00K | -275.00K |
| Total Common Equity | 61.01M | 87.77M | 119.83M | -183.47M | -131.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.01M | 87.77M | 119.83M | -183.47M | -131.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.01M | 87.77M | 119.83M | -183.47M | -131.99M |
|
|
|||||